DemeRx
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1951 NW 7th Ave Ste 600, Miami, Florida,...Phone Number
(786) 347-3500Website
www.demerx.comRevenue
<$5 MillionIndustry
About DemeRx
DemeRx Org Chart
Is DemeRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when DemeRx launches new products
Check out if DemeRx is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at DemeRx
Earning: See what the market has to say on DemeRx recently announced quarterly report
Click to see if DemeRx had a recent Job posting/layoffs
Check if DemeRx has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once DemeRx has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
DemeRx, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at DemeRx
Find 3 more new buyers
Compare Similar Companies to DemeRx
Compare insights from companies similar to DemeRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
DemeRx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
DemeRx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DemeRx.
DemeRx Tech Stack
A closer look at the technologies used by DemeRx
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DemeRx
DemeRx is a clinical-stage biopharmaceutical company focused on developing innovative treatments for alcohol use disorder (AUD) through its investigational therapy DMX-1001, an oral form of noribogaine. The company aims to transform addiction therapeutics by addressing the underlying neuroplasticity issues that traditional treatments often overlook... Read More